STOCK TITAN

[Form 4] MEDICAL PROPERTIES TRUST INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Medical Properties Trust insider share grants and vesting details

SVP of Operations Rosa Handley was granted two non‑cash awards on 09/24/2025: 36,765 shares that vest quarterly through March 31, 2028 and 15,420 performance‑based shares tied to three‑year total shareholder return (TSR) hurdles through April 14, 2028. The performance shares pay out 100% at 20% TSR, 200% at 40% TSR and 300% at 60% TSR with linear interpolation for intermediate results; earned shares vest quarterly over one year or immediately upon final committee determination. Reported beneficial ownership after transactions is 400,743 shares (direct).

Dettagli sulle assegnazioni e sul vesting delle azioni da parte degli insider di Medical Properties Trust

Rosa Handley, Senior Vice President Operations, ha ricevuto due premi non in contanti il 24/09/2025: 36.765 azioni che vestono trimestralmente entro il 31 marzo 2028 e 15.420 azioni basate sulla performance legate a soglie di ritorno per azionista totale (TSR) su tre anni entro il 14 aprile 2028. Le azioni basate sulla performance pagano il 100% a TSR del 20%, il 200% a TSR del 40% e il 300% a TSR del 60%, con interpolazione lineare per risultati intermedi; le azioni maturate vestono trimestralmente nell'arco di un anno o immediatamente dopo la determinazione finale del comitato. La proprietà utile riportata dopo le transazioni è di 400.743 azioni (dirette).

Detalles de asignaciones de acciones de insider de Medical Properties Trust y vesting

Rosa Handley, SVP de Operaciones, recibió dos premios no monetarios el 24/09/2025: 36.765 acciones que se consolidan trimestralmente hasta el 31 de marzo de 2028 y 15.420 acciones basadas en rendimiento vinculadas a umbrales de rendimiento total para el accionista (TSR) de tres años hasta el 14 de abril de 2028. Las acciones de rendimiento pagan un 100% a un TSR del 20%, 200% a 40% y 300% a 60%, con interpolación lineal para resultados intermedios; las acciones ganadas se consolidan trimestralmente durante un año o inmediatamente tras la determinación final del comité. La propiedad beneficiosa reportada tras las transacciones es de 400.743 acciones (directas).

Medical Properties Trust 내부자 주식 부여 및 vesting 세부 정보

운영 수석 부사장 로사 핸들리는 2025년 9월 24일 비현금 보상 2건을 수여받았습니다: 36,765주가 2028년 3월 31일까지 분기별로 vest되고 15,420주가 3년간의 총주주수익(TSR) 장벽과 연동된 성과 기반 주식으로 2028년 4월 14일까지 vest합니다. 성과 주식은 TSR이 20%일 때 100%, TSR이 40%일 때 200%, TSR이 60%일 때 300%를 지급하며, 중간 결과에 대해서는 선형 보간을 적용합니다; 획득한 주식은 1년 동안 분기별로 vest되거나 위원회 최종 결정 시 즉시 vest합니다. 거래 후 보고된 유익 소유권은 직계로 400,743주입니다.

Détails des attributions et de la mise en vesting des actions des initiés de Medical Properties Trust

Rosa Handley, vice-présidente principale des Opérations, a reçu deux récompenses non monétaires le 24/09/2025: 36 765 actions qui se mettent en vesting trimestriellement jusqu’au 31 mars 2028 et 15 420 actions basées sur la performance liées à des seuils de rendement total pour les actionnaires (TSR) sur trois ans jusqu’au 14 avril 2028. Les actions de performance versent 100 % à un TSR de 20 %, 200 % à 40 % et 300 % à 60 %, avec interpolation linéaire pour les résultats intermédiaires; les actions acquises se vestent trimestriellement sur un an ou immédiatement après la détermination finale du comité. La propriété bénéficiaire reportée après les transactions est de 400 743 actions (directes).

Insider-Zuweisungen und Vesting-Details bei Medical Properties Trust

Rosa Handley, Senior Vice President Operations, erhielt am 24.09.2025 zwei nicht in Bargeld bestehende Awards: 36.765 Aktien, die vierteljährlich bis zum 31.03.2028 vesten, und 15.420 leistungsbasierte Aktien, die an dreijährige Total Shareholder Return (TSR)-Hürden bis zum 14.04.2028 gebunden sind. Die Leistungsaktien zahlen 100% bei 20% TSR, 200% bei 40% TSR und 300% bei 60% TSR, mit linearer Interpolation für Zwischenwerte; erworbene Aktien vesten vierteljährlich über ein Jahr oder sofort nach der endgültigen Feststellung des Ausschusses. Die nach Transaktionen gemeldete beherrschende Eigentümerschaft beträgt 400.743 Aktien (direkt).

تفاصيل منح الأسهم للمطلعين ومرحلة الت vesting لدى Medical Properties Trust

تم منح نائب رئيس العمليات الأول روزا هاندلي جائزتين غير نقديتين في 2025-09-24: 36,765 سهماً يتم vestingها ربع سنوياً حتى 31 مارس 2028 و15,420 سهماً قائمًا على الأداء مرتبطاً بعقبات TSR (إجمالي عائد المساهمين) لمدة ثلاث سنوات حتى 14 أبريل 2028. تدفع أسهم الأداء 100% عند TSR بنسبة 20%، و200% عند 40%، و300% عند 60%، مع تقاطع خطي للنتائج الوسيطة؛ الأسهم المكتسبة vest خلال سنة واحدة ربع سنوياً أو فور القرار النهائي من اللجنة. الملكية المفيدة المبلغ عنها بعد المعاملات هي 400,743 سهماً (مباشرة).

Medical Properties Trust 内幕股票授予及归属详情

运营高级副总裁 Rosa Handley 于 2025-09-24 获得两项非现金奖励:36,765 股按季度在 2028-03-31 前分期归属,以及 15,420 股基于绩效的股票,基于三年总股东回报(TSR)门槛,直至 2028-04-14 归属。绩效股在 TSR 为 20% 时支付 100%,在 40% 时为 200%,在 60% 时为 300%,中间结果按线性插值;获得的股票在一年内按季归属,或在委员会最终决定后立即归属。交易后的受益所有权为 400,743 股(直接持有)。

Positive
  • Insider acquisition reported: Rosa Handley received 36,765 time‑vesting shares and 15,420 performance‑based shares on 09/24/2025
  • Performance alignment: Performance shares are tied to explicit TSR hurdles (20%/40%/60%) with up to 300% payout and linear interpolation
  • Clear vesting schedule: Time‑vested shares vest quarterly through March 31, 2028 and earned performance shares vest quarterly over the year following performance determination
Negative
  • None.

Insights

TL;DR: Insider received time‑based and performance‑based equity grants aligning compensation with long‑term TSR.

The grant structure combines quarterly time‑vested shares and multi‑year TSR performance awards, which aligns executive incentives with shareholder returns without immediate cash outlay. The performance hurdles are explicit: 20%/40%/60% TSR tiers with up to 300% payout and interpolation, creating clear pay‑for‑performance targets. The awards will not dilute current holders immediately as they are subject to vesting and performance conditions, and the report shows the holder retains substantial direct ownership (400,743 shares) after the grant.

TL;DR: Grant terms reflect common governance practice: multi‑year performance metrics plus time‑based vesting to retain management.

The combination of TSR‑linked performance awards and quarterly vesting of earned shares is a standard retention and alignment mechanism. The disclosure clearly describes vesting schedule and measurement period, aiding investor assessment of incentive design. No information here indicates change in control, unusual acceleration, or other governance red flags; the filing documents standard Section 16 reporting of an insider award.

Dettagli sulle assegnazioni e sul vesting delle azioni da parte degli insider di Medical Properties Trust

Rosa Handley, Senior Vice President Operations, ha ricevuto due premi non in contanti il 24/09/2025: 36.765 azioni che vestono trimestralmente entro il 31 marzo 2028 e 15.420 azioni basate sulla performance legate a soglie di ritorno per azionista totale (TSR) su tre anni entro il 14 aprile 2028. Le azioni basate sulla performance pagano il 100% a TSR del 20%, il 200% a TSR del 40% e il 300% a TSR del 60%, con interpolazione lineare per risultati intermedi; le azioni maturate vestono trimestralmente nell'arco di un anno o immediatamente dopo la determinazione finale del comitato. La proprietà utile riportata dopo le transazioni è di 400.743 azioni (dirette).

Detalles de asignaciones de acciones de insider de Medical Properties Trust y vesting

Rosa Handley, SVP de Operaciones, recibió dos premios no monetarios el 24/09/2025: 36.765 acciones que se consolidan trimestralmente hasta el 31 de marzo de 2028 y 15.420 acciones basadas en rendimiento vinculadas a umbrales de rendimiento total para el accionista (TSR) de tres años hasta el 14 de abril de 2028. Las acciones de rendimiento pagan un 100% a un TSR del 20%, 200% a 40% y 300% a 60%, con interpolación lineal para resultados intermedios; las acciones ganadas se consolidan trimestralmente durante un año o inmediatamente tras la determinación final del comité. La propiedad beneficiosa reportada tras las transacciones es de 400.743 acciones (directas).

Medical Properties Trust 내부자 주식 부여 및 vesting 세부 정보

운영 수석 부사장 로사 핸들리는 2025년 9월 24일 비현금 보상 2건을 수여받았습니다: 36,765주가 2028년 3월 31일까지 분기별로 vest되고 15,420주가 3년간의 총주주수익(TSR) 장벽과 연동된 성과 기반 주식으로 2028년 4월 14일까지 vest합니다. 성과 주식은 TSR이 20%일 때 100%, TSR이 40%일 때 200%, TSR이 60%일 때 300%를 지급하며, 중간 결과에 대해서는 선형 보간을 적용합니다; 획득한 주식은 1년 동안 분기별로 vest되거나 위원회 최종 결정 시 즉시 vest합니다. 거래 후 보고된 유익 소유권은 직계로 400,743주입니다.

Détails des attributions et de la mise en vesting des actions des initiés de Medical Properties Trust

Rosa Handley, vice-présidente principale des Opérations, a reçu deux récompenses non monétaires le 24/09/2025: 36 765 actions qui se mettent en vesting trimestriellement jusqu’au 31 mars 2028 et 15 420 actions basées sur la performance liées à des seuils de rendement total pour les actionnaires (TSR) sur trois ans jusqu’au 14 avril 2028. Les actions de performance versent 100 % à un TSR de 20 %, 200 % à 40 % et 300 % à 60 %, avec interpolation linéaire pour les résultats intermédiaires; les actions acquises se vestent trimestriellement sur un an ou immédiatement après la détermination finale du comité. La propriété bénéficiaire reportée après les transactions est de 400 743 actions (directes).

Insider-Zuweisungen und Vesting-Details bei Medical Properties Trust

Rosa Handley, Senior Vice President Operations, erhielt am 24.09.2025 zwei nicht in Bargeld bestehende Awards: 36.765 Aktien, die vierteljährlich bis zum 31.03.2028 vesten, und 15.420 leistungsbasierte Aktien, die an dreijährige Total Shareholder Return (TSR)-Hürden bis zum 14.04.2028 gebunden sind. Die Leistungsaktien zahlen 100% bei 20% TSR, 200% bei 40% TSR und 300% bei 60% TSR, mit linearer Interpolation für Zwischenwerte; erworbene Aktien vesten vierteljährlich über ein Jahr oder sofort nach der endgültigen Feststellung des Ausschusses. Die nach Transaktionen gemeldete beherrschende Eigentümerschaft beträgt 400.743 Aktien (direkt).

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Hooper Rosa Handley

(Last) (First) (Middle)
1000 URBAN CENTER DRIVE
SUITE 501

(Street)
BIRMINGHAM AL 35242

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MEDICAL PROPERTIES TRUST INC [ MPW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP of Operations
3. Date of Earliest Transaction (Month/Day/Year)
09/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.001 09/24/2025 A 36,765(1) A $0.00 385,323 D
Common stock, par value $0.001 09/24/2025 A 15,420(2)(3) A $0.00 400,743 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares vest at the beginning of each calendar quarter ending March 31, 2028.
2. The shares were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period ending April 14, 2028 as follows: (i) if the Company's TSR reaches 20%, 100% of the shares will be earned; (ii) if the Company's TSR reaches 40%, 200% of the shares will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the shares will be earned. The actual number of shares to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 3).
3. Earned shares will become vested in equal quarterly installments over one year following the date the shares are earned, provided that all unvested earned shares will vest in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.
W. Zachary Riddle, by power of attorney 09/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did MPW insider Rosa Handley report on Form 4?

The report shows grants on 09/24/2025 of 36,765 time‑vesting shares and 15,420 performance‑based shares under MPW's equity plan.

How do the performance shares for MPW (ticker MPW) vest?

Performance shares are earned based on Company TSR over three years ending 04/14/2028 with payouts at 20%/40%/60% TSR and linear interpolation; earned shares then vest quarterly over one year.

What is Rosa Handley’s beneficial ownership after the reported transactions?

Following the transactions, the filing reports 400,743 shares beneficially owned directly.

Are the granted shares paid in cash or stock for MPW’s Form 4?

The filing reports $0.00 price for the acquisitions, indicating grants of common stock rather than cash purchases.

Who filed the Form 4 on behalf of the reporting person?

The form was signed by W. Zachary Riddle by power of attorney on 09/26/2025.
Medical Prop

NYSE:MPW

MPW Rankings

MPW Latest News

MPW Latest SEC Filings

MPW Stock Data

2.94B
497.16M
17.3%
59.5%
27.66%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
BIRMINGHAM